证券代码：605369 证券简称：拱东医疗 公告编号：2025-032 浙江拱东医疗器械股份有限公司 董事会同意选举施慧勇先生（简历见附件）为代表公司执行公司事务的董事， 并担任公司法定代表人，任期自本次董事会审议通过之日起至公司第三届董事会 任期届满之日止。 （二）审议通过了《关于选举审计委员会成员及推选召集人的议案》 第三届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 浙江拱东医疗器械股份有限公司（以下简称"公司"）第三届董事会第十七 次会议于 2025 年 9 月 18 日在公司三楼会议室以现场结合通讯表决方式召开。全 体董事同意豁免本次会议通知时间要求。本次会议由董事长施慧勇先生主持，会 议应出席董事 8 人，实际出席董事 8 人（其中以通讯表决方式出席会议的董事 4 人）。公司监事、高级管理人员列席本次会议。本次会议的召集、召开符合有关 法律、行政法规、部门规章、规范性文件和《公司章程》的规定，决议内容合法 有效。 二、董事会会议审议情况 （一）审议通过了《关于选 ...

Group 1 - The stock price of Gongdong Medical (605369) closed at 19.42 yuan on September 5, 2025, down 2.41% from 19.9 yuan the previous week [1] - The highest intraday price for Gongdong Medical on September 1 was 19.99 yuan, while the lowest intraday price on September 5 was 19.12 yuan [1] - The current total market capitalization of Gongdong Medical is 4.282 billion yuan, ranking 86th out of 126 in the medical device sector and 3671st out of 5152 in the A-share market [1] Group 2 - Gongdong Medical announced a share reduction plan on September 5, 2025, where controlling shareholder Shi Huiyong plans to reduce his holdings by up to 4,409,858 shares, not exceeding 2% of the total share capital [2] - Taizhou Jincheng Investment Management Partnership plans to reduce its holdings by up to 2,204,929 shares, not exceeding 1% of the total share capital [2] - Shi Huiyong and Jincheng Investment are acting in concert, holding a combined 64.21% of the shares [3]

Group 1 - Huaneng Power announced that its shareholder Hunan Energy Group plans to reduce its stake by up to 20.31 million shares, not exceeding 1% of the total share capital [1] - Ankai Bus reported a production of 1,012 buses in August, a year-on-year increase of 68.06%, with sales of 773 buses, up 46.95% year-on-year [1] - Lianhuan Pharmaceutical received a drug registration certificate for Famotidine injection, classified as a Class 3 chemical drug [1][2] Group 2 - Dongrui Co. reported sales of 94,800 pigs in August, generating revenue of 160 million yuan, a month-on-month decrease of 5.48% [3] - Tiancheng Control's subsidiary received a notification for a passenger car seat assembly project, expected to start production in April 2026 [5] - ST Huluwa obtained a drug registration certificate for Cefodizime capsules, a third-generation broad-spectrum cephalosporin [6] Group 3 - Jiulong Biotech announced the resignation of its Vice Chairman and General Manager Liang Hongjun due to work adjustments [8] - Guanhua High-tech's shareholder plans to reduce its stake by up to 17.50 million shares, not exceeding 1% of the total share capital [9] - Hebei Steel received approval to issue bonds totaling up to 10 billion yuan [10] Group 4 - Yunnan Energy Investment's subsidiaries received a total of 309 million yuan in renewable energy price subsidies [12] - Zhenghong Technology reported sales of 16,800 pigs in August, with a revenue of 22.87 million yuan, showing a year-on-year increase in sales volume of 63.31% [14] - Jilin Aodong's subsidiary received a drug registration certificate for a solution used in asthma treatment [16] Group 5 - Aonong Biological reported a 26.84% year-on-year increase in pig sales volume in August, reaching 150,100 pigs [18] - Xingdesheng announced a share repurchase plan with a budget of 15 to 30 million yuan [20] - Yueyang Lin Paper's Chairman Ye Meng resigned due to work adjustments [22] Group 6 - Kangchen Pharmaceutical's controlling shareholder plans to reduce its stake by up to 4.78 million shares, not exceeding 3% of the total share capital [23] - Changchun Yidong's General Manager Liu Xiaodong resigned due to work adjustments [25] - Zhongzai Resources' subsidiary received a government subsidy of 12.75 million yuan [26] Group 7 - Tianyu Biological reported a 41.89% month-on-month increase in sales revenue from pig sales in August [27] - Changfei Optical's shareholder Draka Comteq B.V. reduced its stake from 10% to 5% [27] - Zhongchuan Technology's Chairman Wu Xingwang resigned due to work adjustments [28] Group 8 - Huakang Clean announced a successful bid for a medical service construction project valued at 131 million yuan [29] - Yuegui Co. plans to establish a wholly-owned subsidiary with a registered capital of 100 million yuan [31] - Baisheng Intelligent's Vice General Manager and Board Secretary Huang Lijun resigned for personal reasons [32] Group 9 - Jiangsu Shuntian will change its stock name to "Suhao Fashion" starting September 10, 2025 [34] - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.3759 million shares, not exceeding 1% of the total share capital [35] - Heng Rui Pharmaceutical received approval for clinical trials of HRS-4729 injection [37] Group 10 - Changfei Optical's shareholder plans to reduce its stake by up to 110,000 shares, not exceeding 0.15% of the total share capital [39] - Yutong Bus reported sales of 4,260 vehicles in August, a year-on-year increase of 16.78% [40] - JinkoSolar received 646 million yuan in renewable energy subsidies in August, a 248% increase year-on-year [41] Group 11 - Beijing Lier signed a strategic cooperation agreement with SenseTime and Xiwang Technology for AI collaboration [43] - Gongdong Medical's controlling shareholder plans to reduce its stake by up to 3% [44] - Zhonghuan Hailu terminated its control change plan and resumed trading [46] Group 12 - Longzi Co. reported a tax payment of 22.27 million yuan due to a tax audit [48] - Guoguang Chain's controlling shareholder plans to reduce its stake by up to 2.99% [49] - Guoxin Technology successfully tested a new high-performance chip for automotive electronics [50] Group 13 - GF Securities reported a cumulative increase in borrowings exceeding 20% of its net assets [51] - China Construction Bank's subsidiary plans to increase capital by 3 billion yuan [52] - Jifeng Technology plans to establish a wholly-owned subsidiary with a capital of 50 million yuan [53] Group 14 - Jiantou Energy received approval for a stock issuance plan to specific investors [54] - Shanghai Laishi's executives plan to collectively increase their holdings by at least 6 million yuan [55] - Wencan Co. reported a fire incident at its subsidiary, with no casualties reported [56]

Core Viewpoint - The announcement of share reduction plans by the major shareholders of Gongdong Medical indicates a potential liquidity event, with a total of up to 6,614,787 shares, or 3% of the total share capital, set to be sold within the next three months [1][2] Shareholder Reduction Plans - The controlling shareholder, Shi Huiyong, plans to reduce holdings by up to 4,409,858 shares, which is 2% of the total share capital, through block trading [1] - Taizhou Jincheng Investment Management Partnership intends to reduce holdings by up to 2,204,929 shares, or 1% of the total share capital, via centralized bidding [1] - Combined, the two shareholders will reduce a total of up to 6,614,787 shares, representing 3% of the total share capital [1] Financial Implications - Based on the closing price of 19.38 yuan on September 4, the total cashing out from the planned reductions is approximately 128,194,572.06 yuan [2] - As of the announcement date, Shi Huiyong holds 110,836,040 shares (50.27% of total shares), while Jincheng Investment holds 14,258,009 shares (6.47% of total shares) [2] Shareholding Structure - Shi Huiyong, Shi Yibei, and Jincheng Investment collectively hold 141,558,049 shares, accounting for 64.21% of the total share capital [2] - Jincheng Investment is an employee stock ownership platform, and Shi Huiyong will not participate in this reduction [2] Previous Reduction Activities - Shi Huiyong has previously reduced his holdings by 3,151,400 shares, cashing out approximately 80.36 million yuan [4] - Jincheng Investment has also reduced its holdings by 1,575,700 shares, with a total cashing out of about 43.56 million yuan [5][6] - The cumulative cashing out by both shareholders amounts to approximately 123.92 million yuan [6]

Key Points - Zhonghuan Hailu terminated the planning of the change of company control and resumed trading [1][2] - Shida Shenghua plans to establish a subsidiary with an investment of 25 million yuan to build a 53,000 tons/year calcium chloride project [1] - Southeast Network Frame won a bid for approximately 1.686 billion yuan for the Pujiang Street Five Villages joint planning and development project [1] - Roman Co. intends to acquire 39.2308% equity of Wutong Gaoxin for 196 million yuan [1] - Torch Electronics completed a share repurchase, having repurchased shares worth 49.9907 million yuan [1] - Jiangling Motors reported cumulative sales of 226,500 vehicles from January to August, a year-on-year increase of 5.67% [1] - Wen's Co. reported August sales revenue of 2.956 billion yuan for broilers and 4.825 billion yuan for live pigs [2] - Some directors and senior management of Shanghai Caishi plan to increase their holdings by no less than 6 million yuan [1] - Actual controller of Gongdong Medical, Shi Huiyong, plans to reduce holdings by no more than 4.4099 million shares through block trading [1] - Shida Shenghua's subsidiary establishment and investment in the calcium chloride project indicates growth in the chemical industry [1]

Group 1: Company Announcements - Heng Rui Medicine has received the clinical trial approval notice for HRS-4729 injection, a self-developed peptide drug targeting GLP-1R, GIPR, and GCGR receptors, with no similar products approved in the market [1] - Hubei Yihua has successfully launched its 200,000 tons/year caustic soda project, aimed at upgrading its chlor-alkali chemical industry and enhancing market competitiveness [2] - Ji Min Health announced that its shareholder, Shuangge Group, plans to reduce its stake by up to 3%, equating to a maximum of 15.75 million shares [3] - China Shipbuilding intends to absorb and merge with China Shipbuilding Industry Corporation through a share exchange, with the latter's A-shares set to be delisted on September 5, 2025 [4] - Changfei Fiber reported that its shareholder, Changjiang Communication, plans to reduce its stake by up to 0.15%, totaling no more than 1.1 million shares [5] Group 2: Strategic Collaborations and Developments - Beijing Lier has signed a strategic cooperation agreement with SenseTime and Xiwang Technology to explore AI computing power collaboration and related applications [6] - Junsheng Electronics is collaborating with leading clients like Zhiyuan Robotics, having achieved bulk supply of customized main control boards and various sensors [7][8] - Guoxin Technology has successfully tested a new generation of high-performance chips for automotive electronic BLDC motor control, aimed at addressing the MCU chip shortage in the automotive sector [9] Group 3: Other Corporate Actions - Guoguang Chain's actual controller plans to reduce their stake by up to 2.99%, totaling a maximum of 12.506 million shares [10] - Zhonghuan Hailu has terminated its control change plan, with its stock set to resume trading on September 5, 2025 [11] - Various companies have reported significant project wins, including Ningbo Construction winning contracts worth 1.117 billion yuan [12]

Core Points - Gongdong Medical announced that as of the disclosure date, the controlling shareholder and actual controller, Shi Huiyong, holds 110,836,040 shares, accounting for 50.27% of the total share capital [2] - Taizhou Jinch Investment Management Partnership holds 14,258,009 shares, representing 6.47% of the total share capital [2] - Shi Huiyong plans to reduce his holdings by no more than 4,409,858 shares through block trading within three months after the disclosure date, with a limit of 2% of the total share capital within any consecutive 90 days [2] - Jinch Investment intends to reduce its holdings by no more than 2,204,929 shares through centralized bidding, which is also limited to 1% of the total share capital [2]

Group 1 - Shanghai Laishi's executives plan to collectively increase their holdings in the company by no less than 6 million yuan [1] - Noli Co., Ltd.'s actual controller and its concerted parties plan to reduce their holdings by no more than 3.11% [1] - Gongdong Medical's actual controller and concerted parties plan to reduce their holdings by no more than 3% [1] Group 2 - Jimin Health's actual controller's concerted party plans to reduce their holdings by no more than 3% [1] - Guoguang Chain's actual controller plans to reduce their holdings by no more than 2.99% [1] - Jiahe Meikang's Hongyun Jiukang plans to reduce their holdings by no more than 1% [1] Group 3 - Bolong Technology's supervisory board chairman plans to reduce their holdings by no more than 0.75% [1] - Changfei Optical Fiber's Yangtze Communication plans to reduce their holdings by no more than 0.15% [1] - Guoci Materials' shareholder Wang Hong plans to reduce their holdings by no more than 3 million shares [1]

证券代码：605369 证券简称：拱东医疗 公告编号：2025-029 浙江拱东医疗器械股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 大股东及董监高持股的基本情况 截至本公告披露日，公司控股股东、实际控制人施慧勇持有公司股份 伙） （以下简称"金驰投资"）持有浙江拱东医疗器械股份有限公司（以下简称"公 司"、"拱东医疗"）股份 14,258,009 股，占公司总股本的 6.47%。 ? 减持计划的主要内容 自本公告披露之日起 15 个交易日后的 3 个月内，公司控股股东、实际控制 人施慧勇拟通过大宗交易方式合计减持数量不超过 4,409,858 股，且在任意连续 易方式合计减持数量不超过 2,204,929 股，即不超过公司总股本的 1%； 在减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发新股、 回购注销股份等股本变动事项，上述减持股份数量将相应进行调整。 一、减持主体的基本情况 | 股东名称 施慧勇 | | | --- | --- | | 控股 ...

浙江拱东医疗器械股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：605369 证券简称：拱东医疗 公告编号：2025-029 重要内容提示： 大股东及董监高持股的基本情况 截至本公告披露日，公司控股股东、实际控制人施慧勇持有公司股份 110,836,040 股，占公司总股本的 50.27%。台州金驰投资管理合伙企业（有限合 伙）（以下简称"金驰投资"）持有浙江拱东医疗器械股份有限公司（以下简称"公 司"、"拱东医疗"）股份 14,258,009 股，占公司总股本的 6.47%。 减持计划的主要内容 自本公告披露之日起 15 个交易日后的 3 个月内，公司控股股东、实际控制 人施慧勇拟通过大宗交易方式合计减持数量不超过 4,409,858 股，且在任意连续 90 日内，减持股份的总数不超过公司总股本的 2%。金驰投资拟通过集中竞价交 易方式合计减持数量不超过 2,204,929 股，即不超过公司总股本的 1%； 在减持计划实施期间，公司若发生派发红利、送红股、转增股本、增发 ...